Abstract
Drug shortages have increased over the past decade, tripling since 2006. Pharmacy material managers are challenged with developing inventory policies given changing demand, limited suppliers, and regulations affecting supply. Pharmaceutical inventory management and patient care are inextricably linked; suboptimal control impacts both patient treatment and the cost of care. We study a perishable inventory problem motivated by challenges in pharmaceutical management. Inpatient hospital pharmacies stock medications in two stages, raw material and finished good (e.g. intravenous). While both stages of material are perishable, the finished form is highly perishable. Pharmacy demand depends on the population and patient conditions. We use a stochastic ‘demand state’ as a surrogate for patient condition and develop a Markov decision process to determine optimal, state-dependent two-stage inventory and production policies. We define two ordering and production scenarios, prove the existence of optimal solutions for both scenarios, and apply this framework to the management of Meropenem.
Similar content being viewed by others
References
Alverson C (2003) Beyond purchasing – managing hospital inventory. Managed Healthcare Executive [WWW document] http://www.managedhealthcareexecutive.com/mhe/article/articleDetail.jsp?id=75802 (accessed 19 February 2012).
American Society of Health-System Pharmacists (ASHP) (2010) Drug summit summary report. 5 November 2010 [WWW document] www.ashp.org/drugshortages/summitreport (accessed 29 September 2011).
Baumer AM, Clark AM, Witmer DR, Geize SB, Vermeulen LC and Deffenbaugh JH (2004) National survey of the impact of drug shortages in acute care hospitals. American Journal of Health-System Pharmacy 61 (19), 2015–2022.
Cohen MA, Pierskalla WP and Yen H (1981) Analysis of ordering and allocation policies for multi-echelon, age-differentiated inventory systems. TIMS Studies in the Management Sciences 16 (1), 353–378.
Descioli D (2005) Differentiating the hospital supply chain for enhance performance. Masters Thesis, Massachusetts Institute of Technology.
Fox ER and Tyler LS (2003) Managing drug shortages: seven years’ experience at one health system. American Journal of Health Systems Pharmacists 60 (3), 245–253.
Fraind DB, Slagle JM, Tubbesing VA, Hughes SA and Weinger MB (2002) Reengineering intravenous drug and fluid administration processes in the operating room: step one: task analysis of existing processes. Anesthesiology 97 (1), 139–147.
Fujiwara O, Soewandi H and Dayani S (1997) An optimal ordering and issuing policy for a two-stage inventory system for perishable products. European Journal of Operational Research 99 (2), 412–424.
Gallego G and Hu H (2004) Optimal policies for production/inventory systems with finite capacity and Markov-modulated demand and supply processes. Annals of Operations Research 126 (1), 21–41.
Gillerman RG and Browning RA (2000) Drug use inefficiency: a hidden source of wasted health care dollars. Anesthesia & Analgesia 91 (4), 921–924.
Goh C, Greenberg B and Matsuo H (1993) Two-stage perishable inventory models. Management Science 39 (5), 633–649.
Goyal SK and Giri BC (2001) Recent trends in modeling of deteriorating inventory. European Journal of Operational Research 134 (1), 1–16.
Haijema R, vanderWal J and vanDijk N (2007) Blood platelet production: optimization by dynamic programming and simulation. Computers & Operations Research 34 (3), 760–779.
Handfield R (2007) Supply Chain Resource Cooperative. Working Paper, College of Management, North Carolina State University.
Harbarth S, Filius PM, Natsch S and Mackenzie F (2007) Shortage of antimicrobial agents in Europe: results of an international survey. 17th European Congress of Clinical Microbiology and Infectious Diseases ICC, Munich, Germany. 31 March-4 April.
Institute of Safe Medication Practices (2010) National survey on drug shortages reveals serious impact of patient safety. [WWW document] http://www.ismp.org/pressroom/PR20100923.pdf (accessed 19 February 2012).
Karaesmen I, Scheller-Wolf A and Deniz B (2011) Managing perishable and aging inventories: review and future research directions. In Planning in the Extended Enterprise: A State of the Art Handbook. 2011 (KESKINOCAK P, KEMPF K and UZSOY R, Eds), pp 393–436, Springer, New York, NY.
Ketzenberg ME and Ferguson M (2008) Managing slow-moving perishables in the grocery industry. Production and Operations Management 17 (5), 513–521.
Kwak NK, Stanley D and Durbin E (1991) An inventory model for optimizing purchasing of intravenous fluids for hospitals. Journal of Medical Systems 15 (2), 171–181.
Little J and Coughlan B (2008) Optimal inventory policy within hospital space constraints. Health Care Management Science 11 (2), 177–183.
Lystad E, Ferguson M and Alexopoulos C (2006) Single stage heuristic for perishable inventory control in two-echelon supply chains. Unpublished Ph.D. Dissertation, Georgia Institute of Technology, USA.
Merrem® I.V. (2009) (Meropenem) Prescribing Information. AstraZeneca Pharmaceuticals, July, http://www1.astrazeneca-us.com/pi/merremiv.pdf.
Prastacos GP (1981) Allocation of perishable product inventory. Operations Research 29 (1), 95–107.
Rosales CR (2011) Technology enabled new inventory control policies in hospitals. Ph.D. Dissertation. University of Cincinnati.
Strausbaugh LJ, Jernigan DB and Liedtke LA (2001) National shortages of antimicrobial agents: Results of 2 surveys from the IDSA Emerging Infections Network. Clinical Infectious Diseases 33 (9), 1495–1501.
Weinger MB (2001) Drug wastage contributes significantly to the cost of routine anesthesia care. Journal of Clinical Anesthesiology 13 (7), 491–497.
Acknowledgements
The research presented in this paper was supported in part by the Agency for Healthcare Research and Quality (AHRQ) under the grant number 1R36HS017756-01.
Author information
Authors and Affiliations
Corresponding author
Appendix
Appendix
Proof of Lemma 1:
-
For a fixed (z, R) there is a finite x1*(z, R) which exists such that L is convex in x and L x (z, R, x1*(z, R))=0
Using the Dominated Convergence Theorem (DCT) we can observe that the following relationships exist.
For these relationships to hold, b2 must be greater than the production cost (i.e., expediting must be more costly than production) and the cost w2 must be greater than or equal to w1, that is, the finished good is at least as valuable as the raw material. Therefore, for a fixed (z, R) the single period cost function L (z, R, x) is convex in x and an optimal solution to the minimization function v1(z, R) exists and is defined as x1*(z, R).
Proof of Lemma 2:
-
Define R(z) as the raw material order quantity when the demand process is initially in state z. For a fixed demand state, z, there is a finite R*(z) which exists such that
Therefore, for a fixed z and any production quantity, x, the single period cost function L (z, R, x) is convex in R, and an optimal solution to the minimization function v1(z, R) exists and is defined as R*(z).
Recall that L is our single period cost function (Eq. 3) when the demand is in state z, the raw material inventory is R, and the production decision is x. Now if we assume that the decision R can be continuous but the decision x is discrete, we must prove that there still exists an optimal solution for x. The following Proposition defines the analog to Lemma 1.
Proposition 1:
-
If κ(x) is a real-valued function of x∈X where X is a bounded subset of Z, and if Δ2κ(x)⩾0 for all x∈Z, then every local minimum of κ(x) is also a global minimum of κ(x) on X.
Proof:
-
In order to prove that the proposition is true, we must develop the first difference equation. We define the first difference as where Δf(x)=f(c+h)−f(c) where h is defined as the increment. Rewriting Eq. (3.3) as its discrete counterpart below, the first difference in developed as a function of the decision variable x.
The last term can be further simplified as follows:
Defining the second difference as Δ2f(x)≡f(c+2 h)−2f(c+h)+f(c), we next evaluate the resulting second difference for the single period problem in order to determine if an optimal production decision exists.
Thus, Proposition 1 is proven for the single period problem.
The multi-period problem extends the single period total expected cost function by the addition of positive expected cost. It immediately follows that Proposition 1 holds for the n period problem and thus the second difference for the multi-period total expected cost function v has a positive second difference.
Rights and permissions
About this article
Cite this article
Vila-Parrish, A., Ivy, J., King, R. et al. Patient-based pharmaceutical inventory management: a two-stage inventory and production model for perishable products with Markovian demand. Health Syst 1, 69–83 (2012). https://doi.org/10.1057/hs.2012.2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1057/hs.2012.2